Antibacterial activity of probiotic strains of lactobacilli included in the MRM Nutrition Women’s Probiotic complex (Lactobacillus plantarum LP01 and Lactobacillus paracasei LPC09)
Budilovskaya O.V., Spasibova E.V., Khusnutdinova T.A., Krysanova A.A., Shalepo K.V., Savicheva A.M.
Lactobacilli, recognized as probiotics, are regarded as promising instruments, both for the prevention and treatment of vaginal dysbiosis and urinary tract infection. Given the ineffectiveness of therapy and the frequent recurrence of these infections, the use of probiotics has become a progressive solution to this problem.
Objective: To evaluate the antibacterial activity of probiotic strains of lactobacilli included in the MRM Nutrition Women's Probiotic complex (Lactobacillus plantarum LP01 and Lactobacillus paracasei LPC09) against opportunistic bacteria isolated from urogenital clinical materials, and to determine the sensitivity of these lactobacilli to antibacterial drugs.
Materials and methods: Probiotic strains of Lactobacillus plantarum LP01 and Lactobacillus paracasei LPC09 were cultivated and the grown colonies were identified using the MALDI-TOF mass spectrometry method (Bruker, Germany). To study the antagonism between probiotic strains of lactobacilli and opportunistic microorganisms, a collection of 16 clinical isolates of opportunistic microorganisms was made: Escherihia coli (3), Klebsiella pneumoniae (2), Morganella morganii (1), Enterococcus faecalis (3), Enterococcus raffinosus (1), Streptococcus agalactiae (3), Staphylococcus epidermidis (1) and Candida albicans (2). To study the sensitivity of probiotic strains of lactobacilli to antimicrobial drugs, a panel for determining the sensitivity of gram-positive bacteria to antimicrobial drugs "Gram-positive AST" (AutoBio Diagnostics, China) was used.
Results: When co-cultivated with probiotic lactobacilli (Lactobacillus plantarum LP01 and Lactobacillus paracasei LPC09), a decrease in the pH of the medium was noted, and a direct antibacterial effect of these lactobacilli against all tested opportunistic microorganisms was detected. When studying antibiotic resistance, it was marked that both strains of lactobacilli were resistant to antibacterial drugs of the penicillin group, cephalosporins, and fluoroquinolones.
Conclusion: Oral administration of the MRM Nutrition Women's Probiotic complex, containing a combination of Lactobacillus plantarum LP01 and Lactobacillus paracasei LPC09, cranberry extract and D-mannose, has significant antibacterial activity against opportunistic microorganisms isolated from women’s urogenital tract. These lactobacilli strains are resistant to some antibacterial drugs widely used in clinical practice, which may be the ground for taking this probiotic drug together with prescribed antibiotics.
Authors' contributions: Budilovskaya O.V. – literature review, data analysis, text composition; Shalepo K.V., Spasibova E.V. – study conduction, data analysis; Khusnutdinova T.A., Krysanova A.A. – data analysis, text editing, final approval of the article; Savicheva A.M. – study concept and design, data analysis, final editing. All authors have made significant contribution to the study concept and conduction as well as article conduction, have read and approved the final version of the article before publication.
Conflicts of interest: The authors declare no conflicts of interest in connection with the publication of this article.
Funding: The study was performed without external funding.
Authors' Data Sharing Statement: The data supporting the findings of this study are available on request from the corresponding author after approval from the principal investigator.
For citation: Budilovskaya O.V., Spasibova E.V., Khusnutdinova T.A., Krysanova A.A., Shalepo K.V., Savicheva A.M. Antibacterial activity of probiotic strains of lactobacilli included in the MRM Nutrition Women’s Probiotic complex (Lactobacillus plantarum LP01 and Lactobacillus paracasei LPC09).
Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2025; (8): 187-194 (in Russian)
https://dx.doi.org/10.18565/aig.2025.204
Keywords
oral probiotics
probiotic lactobacilli
Lactobacillus plantarum
Lactobacillus paracasei
opportunistic microorganisms
antibacterial drugs
References
- Öztürk R., Murt A. Epidemiology of urological infections: a global burden. World J. Urol. 2020; 38(11): 2669-79. https://dx.doi.org/10.1007/s00345-019-03071-4
- Çelik H., Kozan E., Caf B.B., Çebi G., Koҫ M. The association between urinary tract infections and diet: a literature review. Discov. Med. 2025; 2: 91. https://dx.doi.org/10.1007/s44337-025-00272-2
- Lehtoranta L., Ala-Jaakkola R., Laitila A., Maukonen J. Healthy vaginal microbiota and influence of probiotics across the female life span. Front. Microbiol. 2022; 13: 819958. https://dx.doi.org/10.3389/fmicb.2022.819958
- Cappello C., Acin-Albiac M., Pinto D., Polo A., Filannino P., Rinaldi F. et al. Do nomadic lactobacilli fit as potential vaginal probiotics? the answer lies in a successful selective multi-step and scoring approach. Microb. Cell Fact. 2023; 22(1): 27. https://dx.doi.org/10.1186/s12934-023-02030-4
- Das S., Bhattacharjee M.J., Mukherjee A.K., Khan M.R. Recent advances in understanding of multifaceted changes in the vaginal microenvironment: implications in vaginal health and therapeutics. Crit. Rev. Microbiol. 2023; 49(2): 256-82. https://dx.doi.org/10.1080/1040841X.2022.2049696
- Mei Z., Li D. The role of probiotics in vaginal health. Front. Cell. Infect. Microbiol. 2022; 12: 963868. https://dx.doi.org/10.3389/fcimb.2022.963868
- Zheng J., Wittouck S., Salvetti E., Franz C.M.A.P., Harris H.M.B., Mattarelli P. et al. A taxonomic note on the genus Lactobacillus: Description of 23 novel genera, emended description of the genus Lactobacillus Beijerinck 1901, and union of Lactobacillaceae and Leuconostocaceae. Int. J. Syst. Evol. Microbiol. 2020; 70(4): 2782-858. https://dx.doi.org/10.1099/ijsem.0.004107
- Piccioni A., Franza L., Vaccaro V., Saviano A., Zanza C., Candelli M. et al. Microbiota and probiotics: the role of Limosilactobacillus reuteri in diverticulitis. Medicina (Kaunas). 2021; 57(8): 802. https://dx.doi.org/10.3390/medicina57080802
- Будиловская О.В., Спасибова Е.В., Шалепо К.В., Хуснутдинова Т.А., Крысанова А.А., Синякова А.А., Беспалова О.Н., Савичева А.М. Антагонистическая и антибактериальная активность Lactobacillus rhamnosus HN001 и Lactobacillus acidophilus La-14, входящих в состав перорального пробиотика. Журнал акушерства и женских болезней. 2024; 73(3): 27-39. [Budilovskaya O.V., Spasibova E.V., Shalepo K.V., Khusnutdinova T.A., Krysanova A.A., Siniakova A.A., Bespalova O.N., Savicheva A.M. Antagonistic and antibacterial activity of Lactobacillus rhamnosus HN001 and Lactobacillus acidophilus La-14 included in the oral probiotic. Journal of obstetrics and women's diseases. 2024; 73(3): 27-39 (in Russian)]. https://dx.doi.org/10.17816/JOWD630698
- Novak J., Ravel J., Ma B., Ferreira C.S.T., Tristão A.D.R., Silva M.G. et al. Characteristics associated with Lactobacillus iners-dominated vaginal microbiota. Sex. Transm. Infect. 2022; 98(5): 353-9. https://dx.doi.org/10.1136/sextrans-2020-054824
- Marrazzo J.M., Fiedler T.L., Srinivasan S., Thomas K.K., Liu C., Ko D. et al. Extravaginal reservoirs of vaginal bacteria as risk factors for incident bacterial vaginosis. J. Infect. Dis. 2012; 10(205): 1580-8. https://dx.doi.org/10.1093/infdis/jis242
- Леонова М.В. Пробиотики в лечении вагинальных инфекций: эффективность с позиции доказательной медицины. Медицинский совет. 2020; 13: 148-54. [Leonova M.V. Probiotics in the treatment of vaginal infections: efficacy from the perspective of evidence-based medicine. Medical Council. 2020; (13): 148-54 (in Russian)]. https://dx.doi.org/10.21518/2079-701X-2020-13-148-154
- Reid G. The scientific basis for probiotic strains of lactobacillus. Appl. Environ. Microbiol. 1999; 65(9): 3763-6. https://dx.doi.org/10.1128/AEM.65.9.3763-3766.1999
- Conway P.L., Gorbach S.L., Goldin B.R. Survival of lactic acid bacteria in the human stomach and adhesion to intestinal cells. J. Dairy Sci. 1987; 70(1): 1-12. https://dx.doi.org/10.3168/jds.S0022-0302(87)79974-3
- González de Llano D.G., Moreno-Arribas M.V., Bartolomé B. Cranberry polyphenols and prevention against urinary tract infections: relevant considerations. Molecules. 2020; 25(15): 3523. https://dx.doi.org/10.3390/molecules25153523
- Тетерина Т.А., Тарнаева Л.А., Аполихина И.А. Применение D- маннозы в профилактике рецидивирующих инфекций мочевыводящих путей. Фарматека. 2024; 31(3): 26-35. [Teterina T.A., Tarnaeva L.A., Apolikhina I.A. The use of D-mannose in the prevention of recurrent urinary tract infections. Pharmateca. 2024; 31(3): 26-35 (in Russian)]. https://dx.doi.org/10.18565/pharmateca.2024.3.26-35
- González de Llano D., Liu H., Khoo C., Moreno-Arribas M.V., Bartolomé B. Some new findings regarding the antiadhesive activity of cranberry phenolic compounds and their microbial-derived metabolites against uropathogenic bacteria. J. Agric. Food Chem. 2019; 67(8): 2166-74. https://dx.doi.org/10.1021/acs.jafc.8b05625
- Китайский комитет содействия развитию международной торговли. Китайская палата международной торговли. Инструкция по применению. Набор реагентов Gram Positive bacteria AST для определения чувствительности к антимикробным препаратам на анализаторе AutoMic-i600 для in vitro диагностики. Китай; 2023. 23 с. [China Council for the Promotion of International Trade. China Chamber of International Commerce. Instruction for use. Gram Positive bacteria AST reagent for sensitivity testing to antimicrobial drug on the analyzer AutoMic-i600 for in vitro diagnostics. China; 2023. 23 p. (in Russian)]. https://docs.nevacert.ru/files/med_reestr_v2/73173_instruction.pdf
- Nader-Macías M.E.F., De Gregorio P.R., Silva J.A. Probiotic lactobacilli in formulas and hygiene products for the health of the urogenital tract. Pharmacol. Res. Perspect. 2021; 9(5): e00787. https://dx.doi.org/10.1002/prp2.787
- Lewis A.J., Richards A.C., Mendez A.A., Dhakal B.K., Jones T.A., Sundsbak J.L. et al. Plant phenolics inhibit focal adhesion kinase and suppress host cell invasion by uropathogenic Escherichia coli. Infect. Immun. 2024; 92(5): 0008024. https://dx.doi.org/10.1128/iai.00080-24
- Pino A., Vaccalluzzo A., Caggia C., Balzaretti S., Vanella L., Sorrenti V. et al. Lacticaseibacillus rhamnosus CA15 (DSM 33960) as a candidate probiotic strain for human health. Nutrients. 2022; 14(22): 4902. https://dx.doi.org/10.3390/nu14224902
- Leccese Terraf M.C., Juarez Tomás M.S., Rault L., Le Loir Y., Even S., Nader-Macías M.E.F. In vitro effect of vaginal lactobacilli on the growth and adhesion abilities of uropathogenic Escherichia coli. Arch. Microbiol. 2017; 199(5):767-74. https://dx.doi.org/10.1007/s00203-016-1336-z
- Zhang Z., Wang X., Li F. An exploration of alginate oligosaccharides modulating intestinal inflammatory networks via gut microbiota. Front. Microbiol. 2023; 14: 1072151. https://dx.doi.org/10.3389/fmicb.2023.1072151
- Шалепо К.В., Спасибова Е.В., Будиловская О.В., Крысанова А.А., Хуснутдинова Т.А., Чеберя А.С., Чеберя А.Р., Савичева А.М. Оценка эффективности in vitro компонентов препарата «Депантол» против биопленок, сформированных вагинальными микроорганизмами. Акушерство и гинекология. 2024; 10: 158-66. [Shalepo K.V., Spasibova E.V., Budilovskaya O.V., Krysanova A.A., Khusnutdinova T.A., Cheberya A.S., Cheberya A.R., Savicheva A.M. Evaluation of the in vitro effectiveness of the Depantol components on biofilms produced by vaginal microorganisms. Obstetrics and Gynecology. 2024; (10): 158-66 (in Russian)]. https://dx.doi.org/10.18565/aig.2024.256
- Akinosoglou K., Schinas G., Polyzou E., Tsiakalos A., Donders G.G.G. Probiotics in the management of Vulvovaginal Candidosis. J. Clin. Med. 2024; 13(17): 5163. https://dx.doi.org/10.3390/jcm13175163
- Bae W.Y., Lee Y.J., Jo S., Shin S.L., Kim T.R., Sohn M. et al. Effects of Lactiplantibacillus plantarum LM1215 on Candida albicans and Gardnerella vaginalis. Yonsei Med. J. 2024; 65(12): 727-40. https://dx.doi.org/10.3349/ymj.2023.0490
- Tian Q., Ye H., Zhou X., Wang J., Zhang L., Sun W. et al. Evaluating the health risk of probiotic supplements from the perspective of antimicrobial resistance. Microbiol. Spectr. 2025; 13(1): e0001924. https://dx.doi.org/10.1128/spectrum.00019-24
Received 28.07.2025
Accepted 11.08.2025
About the Authors
Olga V. Budilovskaya, PhD, Senior Researcher at the Experimental Microbiology Group, D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology,199034, Russia, St. Petersburg, Mendeleevskaya Line, 3; Teaching Assistant at the Department of Medical Microbiology and Clinical Laboratory Diagnostics of AF and DPO, St. Petersburg State Pediatric Medical University, Ministry of Health of Russia, 194100, Russia, St. Petersburg, Litovskaya str., 2, +7(911)912-77-52, o.budilovskaya@gmail.com, https://orcid.org/0000-0001-7673-6274
Elena V. Spasibova, Bacteriologist at the Laboratory of Clinical Microbiology, D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology, 199034, Russia,
St. Petersburg, Mendeleevskaya Line, 3; Teaching Assistant at the Department of Medical Microbiology and Clinical Laboratory Diagnostics of FP and DPO, St. Petersburg State Pediatric Medical University, Ministry of Health of Russia, 194100, Russia, St. Petersburg, Litovskaya str., 2, elena.graciosae@gmail.com,
https://orcid.org/0009-0002-6070-4651
Tatiana A. Khusnutdinova, PhD, Senior Researcher at the Experimental Microbiology Group, D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology, 199034, Russia, St. Petersburg, Mendeleevskaya Line, 3; Teaching Assistant at the Department of Medical Microbiology and Clinical Laboratory Diagnostics of AF and DPO, St. Petersburg State Pediatric Medical University, Ministry of Health of Russia, 194100, Russia, St. Petersburg, Litovskaya str., 2, +7(981)725-96-90, husnutdinovat@yandex.ru, https://orcid.org/0000-0002-2742-2655
Kira V. Shalepo, PhD, Senior Researcher at the Experimental Microbiology Group, D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology, 199034, Russia, St. Petersburg, Mendeleevskaya Line, 3; Teaching Аssistant at Department of Medical Microbiology and Clinical Laboratory Diagnostics of AF and DPO, St. Petersburg State Pediatric Medical University, Ministry of Health of Russia, 194100, Russia, St. Petersburg, Litovskaya str., 2, +7(911)247-41-51, 2474151@mail.ru,
https://orcid.org/0000-0002-3002-3874
Anna A. Krysanova, PhD, Senior Researcher at the Experimental Microbiology Group, D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology,
199034, Russia, St. Petersburg, Mendeleevskaya Line, 3; Teaching Assistant at the Department of Medical Microbiology and Clinical Laboratory Diagnostics of AF and DPO, St. Petersburg State Pediatric Medical University, Ministry of Health of Russia, 194100, Russia, St. Petersburg, Litovskaya str., 2, +7(911)737-96-93, krusanova.anna@mail.ru, https://orcid.org/0000-0003-4798-1881
Alevtina M. Savicheva, Dr. Med. Sci., Professor, Head of the Laboratory of Microbiology, D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology,
199034, Russia, St. Petersburg, Mendeleevskaya Line, 3; Head of the Department of Medical Microbiology and Clinical Laboratory Diagnostics, St. Petersburg State Pediatric Medical University, Ministry of Health of Russia, 194100, Russia, St. Petersburg, Litovskaya str., 2, +7(921)944-15-47, savitcheva@mail.ru,
https://orcid.org/0000-0003-3870-5930
Corresponding author: Olga V. Budilovskaya, o.budilovskaya@gmail.com
Similar Articles
